Citation Impact
Citing Papers
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
2011
Disease-Promoting Effects of Type I Interferons in Viral, Bacterial, and Coinfections
2015
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Engineering precision nanoparticles for drug delivery
2020 Standout
Immune Response in Hepatitis B Virus Infection
2015
Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection
2018
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
2017 Standout
Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance
2018 StandoutNobel
Evolution in Our Understanding of Hepatitis B Virus Virology and Immunology
2016
A robust cell culture system supporting the complete life cycle of hepatitis B virus
2017 StandoutNobel
Networking at the Level of Host Immunity: Immune Cell Interactions during Persistent Viral Infections
2013
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species
2013 Standout
Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease
2015
The impact of differential antiviral immunity in children and adults
2012
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
2020 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
2013 Standout
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
2014 StandoutNobel
Inflammatory Effects of High and Moderate Intensity Exercise—A Systematic Review
2020 Standout
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Emerging insights into natural killer cells in human peripheral tissues
2016
Natural killer cells in liver disease
2012
Guarding the frontiers: the biology of type III interferons
2015
Living in the liver: hepatic infections
2012
Protective Immunity Against Hepatitis C: Many Shades of Gray
2014
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells
2013
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Upregulation of the Tim-3/Galectin-9 Pathway of T Cell Exhaustion in Chronic Hepatitis B Virus Infection
2012
Optimal management of hepatitis B virus infection – EASL Special Conference
2015
The intestinal epithelial barrier: a therapeutic target?
2016 Standout
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
2016 Standout
Natural history of chronic hepatitis B virus infection
2014
HBV-Induced Immune Imbalance in the Development of HCC
2019
Hepatitis B virus infection
2018
Natural Killer (NK) Cells in Antibacterial Innate Immunity: Angels or Devils?
2011
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Hepatitis C Virus: 30 Years after Its Discovery
2019 StandoutNobel
Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration
2013
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
2020 Standout
The role of innate immunity in the immunopathology and treatment of HBV infection
2016
Immunological memory cells
2018 Standout
Adaptive immunity in HBV infection
2016
Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA
2015 StandoutNobel
Oxidative Stress and Benefits of Antioxidant Agents in Acute and Chronic Hepatitis
2012
Inhibitory Phenotype of HBV-Specific CD4+ T-Cells Is Characterized by High PD-1 Expression but Absent Coregulation of Multiple Inhibitory Molecules
2014
Enhancing Virus-Specific Immunity In Vivo by Combining Therapeutic Vaccination and PD-L1 Blockade in Chronic Hepadnaviral Infection
2014
Molecular and cellular insights into T cell exhaustion
2015 Standout
Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease
2016
Taming a beast: lessons from the domestication of hepatitis C virus
2019 StandoutNobel
Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA
2016 StandoutNobel
Defining and using immune archetypes to classify and treat cancer
2023
Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells
2016 StandoutNobel
Hepatocellular Carcinoma
2019 Standout
Hepatitis B reactivation during or after direct acting antiviral therapy – implication for susceptible individuals
2017
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Genetic Variation at IFNL4 Influences Extrahepatic Interferon-Stimulated Gene Expression in Chronic HCV Patients
2017 StandoutNobel
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease
2018
2014
New Insights into how HBV Manipulates the Innate Immune Response to Establish Acute and Persistent Infection
2013
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Republished: Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
2013
Present and future therapies of hepatitis B: From discovery to cure
2015
Ipilimumab Administration in Patients With Advanced Melanoma and Hepatitis B and C
2013
Sequential Combination Therapy with Pegylated Interferon Leads to Loss of Hepatitis B Surface Antigen and Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Entecavir Treatment
2015
Hepatitis C Virus Testing of Persons Born During 1945–1965: Recommendations From the Centers for Disease Control and Prevention
2012
Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBVin vitroandin vivo
2016
The Role of Oxidative Stress and Antioxidants in Liver Diseases
2015 Standout
Oxidative Stress and Benefits of Antioxidant Agents in Acute and Chronic Hepatitis
2012
Transport and delivery of interferon-α through epithelial tight junctions via pH-responsive poly(methacrylic acid-grafted-ethylene glycol) nanoparticles
2018
Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20
2018 StandoutNobel
New Therapeutic Targets and Drugs for the Treatment of Chronic Hepatitis B
2013
Subsets of human natural killer cells and their regulatory effects
2013
Works of L. Micco being referenced
Vitamins in the treatment of chronic viral hepatitis
2011
Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection
2011
Liver transplantation from hepatitis B surface antigen positive donors: A safe way to expand the donor pool
2011
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B
2012
Blockade of Immunosuppressive Cytokines Restores NK Cell Antiviral Function in Chronic Hepatitis B Virus Infection
2010
Alcohol and viral hepatitis: A mini-review
2008
Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell–mediated deletion
2012